Clinical Trial Update: Pembrolizumab With or Without Lenvatinib or Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial is examining pembrolizumab alone or with lenvatinib or chemotherapy as first-line treatment for advanced biliary tract cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Cholangiocarcinoma
• Gallbladder Cancer

Drugs mentioned

• Chemotherapy (unspecified regimens)
• KEYTRUDA (PEMBROLIZUMAB)
• LENVIMA (lenvatinib)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Biliary Tract Neoplasms Immunotherapy | Phase 2 | Status: RECRUITING